Pharma
Atak Biotech is a distinguished manufacturer of biotechnology medications, dedicated to enhancing global health through its exceptional technical knowledge and extensive experience. Our commitment to innovation and quality drives our mission to provide cutting-edge solutions for healthcare challenges.
With a focus on research and development, we strive to deliver groundbreaking therapies that improve patient outcomes and contribute to the advancement of medical science. At Atak Biotech, we take pride in our role as pioneers in the field, continuously pushing the boundaries of biotechnology to create a healthier world for all.
Epoetin Alfa
(Injection
Route)
Methoxy Polyethylene
Glycol-Epoetin Beta
(Injection Route)
Motixafortide
(Subcutaneous
Route)
Teriparatide
(Subcutaneous
Route)
Streptokinase
(Intravenous Route,
Intracoronary Route)
Rituximab
(Intravenous
Route)
Trastuzumab
(Intravenous
Route)
Adalimumab
(Subcutaneous
Route)
Interferon Gamma-1b
(Injection Route,
Subcutaneous Route)
Interferon Beta-1b
(Subcutaneous
Route)
Follicle Stimulating Hormone
And Luteinizing Hormone (Intramuscular
Route, Subcutaneous Route)